PDT Partners LLC Takes Position in Trupanion, Inc. $TRUP

PDT Partners LLC acquired a new stake in Trupanion, Inc. (NASDAQ:TRUP) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 42,145 shares of the financial services provider’s stock, valued at approximately $1,044,000. PDT Partners LLC owned 0.10% of Trupanion as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of TRUP. BlackRock Inc. bought a new position in shares of Trupanion during the 2nd quarter valued at about $134,774,000. Millennium Management LLC lifted its position in shares of Trupanion by 185.8% during the 3rd quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider’s stock valued at $26,790,000 after acquiring an additional 402,421 shares during the last quarter. Renaissancere Holdings Ltd. bought a new stake in shares of Trupanion during the 2nd quarter worth $6,514,510,000. Goldman Sachs Group Inc. grew its holdings in shares of Trupanion by 116.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 477,014 shares of the financial services provider’s stock worth $17,826,000 after acquiring an additional 256,559 shares during the last quarter. Finally, Two Sigma Investments LP raised its position in shares of Trupanion by 3,201.0% during the third quarter. Two Sigma Investments LP now owns 224,433 shares of the financial services provider’s stock worth $9,713,000 after purchasing an additional 217,634 shares during the period.

Trupanion Stock Down 5.2%

TRUP stock opened at $30.19 on Thursday. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $46.98. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. The company has a market cap of $1.32 billion, a price-to-earnings ratio of 56.96, a PEG ratio of 2.15 and a beta of 1.39. The company has a 50 day moving average of $26.76 and a two-hundred day moving average of $26.00.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, beating the consensus estimate of $0.11 by $0.05. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The business had revenue of $392.93 million for the quarter, compared to analysts’ expectations of $389.72 million. During the same period in the previous year, the company posted $0.22 EPS. Trupanion’s revenue was up 11.1% on a year-over-year basis. On average, equities analysts anticipate that Trupanion, Inc. will post 0.63 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on TRUP shares. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Monday. Stifel Nicolaus upped their price target on shares of Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a research report on Thursday, August 20th. Atlantic Securities set a $42.00 price objective on shares of Trupanion in a research note on Wednesday, July 15th. Piper Sandler cut shares of Trupanion from an “overweight” rating to a “neutral” rating and lowered their price objective for the stock from $45.00 to $32.00 in a research report on Wednesday. Finally, Weiss Ratings raised shares of Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, August 12th. One investment analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $39.20.

Insider Activity at Trupanion

In other news, CEO Margaret Tooth sold 978 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $29.05, for a total transaction of $28,410.90. Following the completion of the sale, the chief executive officer directly owned 175,401 shares of the company’s stock, valued at $5,095,399.05. This trade represents a 0.55% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Fawwad Qureshi sold 6,111 shares of Trupanion stock in a transaction dated Wednesday, August 26th. The shares were sold at an average price of $30.01, for a total value of $183,391.11. Following the sale, the chief financial officer owned 4,230 shares of the company’s stock, valued at approximately $126,942.30. This represents a 59.09% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 15,116 shares of company stock valued at $395,999. Insiders own 5.58% of the company’s stock.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.